Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Investment analysts at Wedbush issued their Q1 2024 earnings estimates for shares of Replimune Group in a research report issued on Monday, May 22nd. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.87) per share for the quarter. The consensus estimate for Replimune […]
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) insider Sushil Patel sold 15,575 shares of the stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $18.05, for a total value of $281,128.75. Following the completion of the transaction, the insider now directly owns 154,571 shares of […]